bioAffinity Technologies (BIAF) Non-cash Items (2022 - 2024)
bioAffinity Technologies has reported Non-cash Items over the past 3 years, most recently at $243097.0 for Q1 2024.
- Quarterly Non-cash Items fell 10.39% to $243097.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $243097.0 through Mar 2024, down 10.39% year-over-year, with the annual reading at $158332.0 for FY2023, 3.61% down from the prior year.
- Non-cash Items was $243097.0 for Q1 2024 at bioAffinity Technologies, up from $158332.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $647793.0 in Q3 2022 and troughed at $158332.0 in Q4 2023.
- The 3-year median for Non-cash Items is $254225.0 (2023), against an average of $287185.4.
- The largest YoY upside for Non-cash Items was 3.61% in 2023 against a maximum downside of 60.76% in 2023.
- A 3-year view of Non-cash Items shows it stood at $164255.0 in 2022, then decreased by 3.61% to $158332.0 in 2023, then soared by 53.54% to $243097.0 in 2024.
- Per Business Quant, the three most recent readings for BIAF's Non-cash Items are $243097.0 (Q1 2024), $158332.0 (Q4 2023), and $254225.0 (Q3 2023).